Subscribe To
Cybersecurity in fintech 2023: protecting customer data and financial systems
As the financial technology (fintech) industry grows and evolves, the necessity for strong cybersecurity measu...
June 27, 2023, 7:30 pm
Here's why you should add 3m (mmm) to your portfolio now
Strength across key end markets, pricing actions and cost-control measures augur well for 3M (MMM). The...
June 27, 2023, 3:03 pm
Canada may cpi 3.4% y/y versus 3.4% expected
Lowest reading since June 2021Prior was 4.4%CPI m/m +0.4% vs +0.5% expectedPrior m/m reading was 0.7%Gasoline prices -18.3% vs -7.7% y/y in prior mont...
June 27, 2023, 12:30 pm
Aussie bounces together with yuan, canadian awaits cpi
In an otherwise lackluster Asian trading session, Chinese actions add a zing today. The rebound in Yuan, propelled by China’s stepped-up ...
June 27, 2023, 5:06 am
Canada may inflation data due on tuesday 27 june 2023 - preview - "look for cpi to fall"
In brief preview from TD on the data due from Canada at 8.30 Eastern time:We look for CPI to fall 0.9% to 3.5% y/y in May0.5% m/m increase to be offse...
June 26, 2023, 10:49 pm
What china’s lackluster stimulus implies for copper and the aussie dollar
China’s supportive measures have been widely criticized, with markets making their dissatisfaction kn...
June 26, 2023, 4:31 pm
Singapore’s central bank launches framework for digital asset networks
The Monetary Authority of Singapore (MAS), also the central bank, has released a report on the framework for creating interoperable networks for digit...
June 26, 2023, 2:04 pm
Crypto.com obtains virtual asset service provider registration in spain
Crypto.com announced today that it has received its Virtual Asset Service Provider (VASP) registration from the Bank of Spain. Crypto.com secured this...
June 26, 2023, 10:31 am
Russell 2000 technical analysis
Following the end of the blackout period after the FOMC meeting, many Fed officials shared their views last week. The prevailing sentiment remains con...
June 26, 2023, 10:04 am
Unifi: changing trade trends could push prices up
Unifi shares have fallen 14% YTD, but there are signs of demand recovery and profitability improvement in Q3 2023. Factors such as normalization of in...
June 26, 2023, 6:15 am
The margin: pride month: these are the 5 most lgbtq-friendly states in the u.s. — and the least
Many states are becoming less friendly to LGBTQ+ people, according to a business-climate index ranking all 50 states on ...
June 25, 2023, 2:04 pm
Data from 89bio’s enliven phase 2b trial of pegozafermin in patients with nonalcoholic steatohepatitis (nash) published in the new england journal of medicine and simultaneously presented in a late-br
– ENLIVEN results demonstrated that treatment with pegozafermin 30mg weekly and 44mg every-two-week doses resulted in statistically significant chan...
June 24, 2023, 9:01 am
Data from 89bio’s enliven phase 2b trial of pegozafermin in patients with nonalcoholic steatohepatitis (nash) published in the new england journal of medicine and simultaneously presented in a late-br
– ENLIVEN results demonstrated that treatment with pegozafermin 30mg weekly and 44mg every-two-week doses resulted in statistically significant chan...
June 24, 2023, 9:01 am
Data from 89bio’s enliven phase 2b trial of pegozafermin in patients with nonalcoholic steatohepatitis (nash) published in the new england journal of medicine and simultaneously presented in a late-br
– ENLIVEN results demonstrated that treatment with pegozafermin 30mg weekly and 44mg every-two-week doses resulted in statistically significant chan...
June 24, 2023, 9:01 am
Data from 89bio’s enliven phase 2b trial of pegozafermin in patients with nonalcoholic steatohepatitis (nash) published in the new england journal of medicine and simultaneously presented in a late-br
– ENLIVEN results demonstrated that treatment with pegozafermin 30mg weekly and 44mg every-two-week doses resulted in statistically significant chan...
June 24, 2023, 9:01 am
Data from 89bio’s enliven phase 2b trial of pegozafermin in patients with nonalcoholic steatohepatitis (nash) published in the new england journal of medicine and simultaneously presented in a late-br
– ENLIVEN results demonstrated that treatment with pegozafermin 30mg weekly and 44mg every-two-week doses resulted in statistically significant chan...
June 24, 2023, 9:01 am
Data from 89bio’s enliven phase 2b trial of pegozafermin in patients with nonalcoholic steatohepatitis (nash) published in the new england journal of medicine and simultaneously presented in a late-br
– ENLIVEN results demonstrated that treatment with pegozafermin 30mg weekly and 44mg every-two-week doses resulted in statistically significant chan...
June 24, 2023, 9:01 am
Is china a bargain bin buy?
Chinese markets and stocks fell this week on lighter-than-hoped-for stimulus measures. China's economic recovery continues to face a number of challen...
June 23, 2023, 5:03 pm
Carmax shares soar after beating quarterly profit and sales estimates
Shares of CarMax jumped on Friday morning after the used car dealer exceeded quarterly earnings and revenue forecasts following cost-cutting measures....
June 23, 2023, 12:25 pm
Intercept announces restructuring to strengthen focus on rare and serious liver diseases and significantly reduce operating expenses
measures reinforce Company’s ability to drive growth in PBC business and continue developing innovati...
June 23, 2023, 10:30 am
